Collectively, these data demonstrate that inhalation of 7, 8-DHF, which pharmacologically enhances TrkB activation in the lung, is a potential pathway for developing treatments aimed at convenient and effective depression therapy. The gene discussed is NTRK2; the disease is depressive symptom measurement.